PURPOSE: To test the hypothesis that four-dimensional (4D) transcatheter intra-arterial perfusion (TRIP) MR imaging can measure uterine fibroid perfusion changes immediately before and after uterine artery embolization (UAE) in the rabbit VX2 tumor model. MATERIALS AND METHODS: Eight VX2 uterine tumors were grown in six rabbits. After positioning a catheter within the uterine artery, we performed 4D TRIP-MRI measurements with 3-mL injections of 2.5% gadopentetate dimeglumine. We used a dynamic 3D spoiled-gradient echo sequence with in vivo B(1)-field correction for improved accuracy during perfusion quantification. We performed UAE using 1 mL of gelatin microspheres (2 x 10(6) particles; diameter 40-120 mum). Two regions-of-interest were drawn within each tumor upon perfusion maps. Functional embolic endpoints were reported as the mean percent reduction in fibroid tumor perfusion. Measurements before and after UAE were compared using paired t-tests (alpha = 0.05). RESULTS: VX2 uterine tumor perfusion decreased significantly from 27.1 at baseline to 7.09 after UAE (mL/min/100 mL of tissue, P < 0.0001). Overall perfusion reduction was 76.3% (95% confidence interval: 66.3-86.3%). CONCLUSION: Four-dimensional TRIP MRI can objectively quantify uterine fibroid perfusion reductions during UAE in VX2 rabbits. This technique could be used clinically to potentially determine an optimal embolic endpoint with the long-term goals of improving UAE success rates and minimizing procedure-related ischemic pain. Copyright 2010 Wiley-Liss, Inc.
PURPOSE: To test the hypothesis that four-dimensional (4D) transcatheter intra-arterial perfusion (TRIP) MR imaging can measure uterine fibroid perfusion changes immediately before and after uterine artery embolization (UAE) in the rabbit VX2 tumor model. MATERIALS AND METHODS: Eight VX2 uterine tumors were grown in six rabbits. After positioning a catheter within the uterine artery, we performed 4D TRIP-MRI measurements with 3-mL injections of 2.5% gadopentetate dimeglumine. We used a dynamic 3D spoiled-gradient echo sequence with in vivo B(1)-field correction for improved accuracy during perfusion quantification. We performed UAE using 1 mL of gelatin microspheres (2 x 10(6) particles; diameter 40-120 mum). Two regions-of-interest were drawn within each tumor upon perfusion maps. Functional embolic endpoints were reported as the mean percent reduction in fibroid tumor perfusion. Measurements before and after UAE were compared using paired t-tests (alpha = 0.05). RESULTS: VX2 uterine tumor perfusion decreased significantly from 27.1 at baseline to 7.09 after UAE (mL/min/100 mL of tissue, P < 0.0001). Overall perfusion reduction was 76.3% (95% confidence interval: 66.3-86.3%). CONCLUSION: Four-dimensional TRIP MRI can objectively quantify uterine fibroid perfusion reductions during UAE in VX2 rabbits. This technique could be used clinically to potentially determine an optimal embolic endpoint with the long-term goals of improving UAE success rates and minimizing procedure-related ischemic pain. Copyright 2010 Wiley-Liss, Inc.
Authors: Isabel Pinto; Paloma Chimeno; Alicia Romo; Laura Paúl; Javier Haya; Miguel A de la Cal; José Bajo Journal: Radiology Date: 2003-02 Impact factor: 11.105
Authors: Andrew C Larson; Thomas K Rhee; Jie Deng; Dingxin Wang; Kent T Sato; Riad Salem; Tatjana Paunesku; Gayle Woloschak; Mary F Mulcahy; Debiao Li; Reed A Omary Journal: J Magn Reson Imaging Date: 2006-07 Impact factor: 4.813
Authors: J H Ravina; D Herbreteau; N Ciraru-Vigneron; J M Bouret; E Houdart; A Aymard; J J Merland Journal: Lancet Date: 1995-09-09 Impact factor: 79.321
Authors: Hyun S Kim; Jason Tsai; Ajanta Patra; Judy M Lee; John G Griffith; Edward E Wallach Journal: J Vasc Interv Radiol Date: 2006-05 Impact factor: 3.464
Authors: Thomas K Rhee; Robert K Ryu; Affaan K Bangash; Dingxin Wang; Barbara Szolc-Kowalska; Kathleen R Harris; Kent T Sato; Howard B Chrisman; Robert L Vogelzang; Tatjana Paunesku; Gayle E Woloschak; Andrew C Larson; Reed A Omary Journal: J Vasc Interv Radiol Date: 2007-03 Impact factor: 3.464
Authors: Wouter J K Hehenkamp; Nicole A Volkers; Peter F J Donderwinkel; Sjoerd de Blok; Erwin Birnie; Willem M Ankum; Jim A Reekers Journal: Am J Obstet Gynecol Date: 2005-11 Impact factor: 8.661
Authors: Nicole A Volkers; Wouter J K Hehenkamp; Erwin Birnie; Willem M Ankum; Jim A Reekers Journal: Am J Obstet Gynecol Date: 2007-06 Impact factor: 8.661